Comparative evaluation of direct thrombin and factor Xa inhibitors with antiplatelet agents under flow and static conditions: an in vitro flow chamber model.
Dabigatran and rivaroxaban are novel oral anticoagulants that specifically inhibit thrombin and factor Xa, respectively. The aim of this study is to elucidate antithrombotic properties of these anticoagulant agents under arterial and venous shear conditions. Whole blood samples treated with dabigatr...
Main Authors: | Kazuya Hosokawa, Tomoko Ohnishi, Hisayo Sameshima, Naoki Miura, Takehiko Koide, Ikuro Maruyama, Kenichi A Tanaka |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3908954?pdf=render |
Similar Items
-
A modified microchip-based flow chamber system for evaluating thrombogenicity in patients with thrombocytopenia
by: Bengo Atari, et al.
Published: (2020-10-01) -
Thrombin and factor Xa link the coagulation system with liver fibrosis
by: Ameet Dhar, et al.
Published: (2018-05-01) -
The tick-derived anticoagulant madanin is processed by thrombin and factor Xa.
by: Ana C Figueiredo, et al.
Published: (2013-01-01) -
Lyso-Sulfatide Binds Factor Xa and Inhibits Thrombin Generation by the Prothrombinase Complex.
by: Subramanian Yegneswaran, et al.
Published: (2015-01-01) -
Factor Xa generation by computational modeling: an additional discriminator to thrombin generation evaluation.
by: Kathleen E Brummel-Ziedins, et al.
Published: (2012-01-01)